Effects of chronic sympatho-inhibition on renal excretory function in renovascular hypertension

Journal of Hypertension

Volumn 29, Issue 5, 2011, Pages 945-952

  Burke, Sandra L ^a   Evans, Roger G ^b   Head, Geoffrey A ^a,c  

^a BAKER IDI HEART AND DIABETES INSTITUTE   (Australia)

^b Department of Physiology ^*  (Australia)

^c MONASH UNIVERSITY   (Australia)

Author keywords

blood pressure; rabbits; renal function; renal sympathetic nerve activity; renin; renovascular hypertension; rilmenidine; sympathetic nervous system

Indexed keywords

RILMENIDINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTERY BLOOD FLOW; ARTERY CLAMP; ARTICLE; EXTRACELLULAR FLUID; FEMALE; GLOMERULUS FILTRATION RATE; KIDNEY BLOOD FLOW; KIDNEY FUNCTION; MALE; MEAN ARTERIAL PRESSURE; MICTURITION; NERVE CONDUCTION; NONHUMAN; PLASMA RENIN ACTIVITY; PRIORITY JOURNAL; RABBIT; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; RENOVASCULAR HYPERTENSION; SODIUM EXCRETION; SYMPATHETIC NERVE; URINARY EXCRETION;

EID: 79954926044     PISSN: 02636352     EISSN: None     Source Type: Journal    
DOI: 10.1097/HJH.0b013e3283449529     Document Type: Article

References (39)

1. De Buyzere ML, Clement DL. Management of hypertension in peripheral arterial disease. Prog Cardiovasc Dis 2008; 50:238-263. (Pubitemid 350301981)
2. Mancia G, De Backer G, Dominiczak A, Cifkova R, Fagard R, Germano G, et al. 2007 Guidelines for the Management of Arterial Hypertension: the Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). J Hypertens 2007; 25:1105-1187. (Pubitemid 46924065)
3. Edwards MS, Corriere MA. Contemporary management of atherosclerotic renovascular disease. J Vasc Surg 2009; 50:1197-1210.
4. Hall JE, Guyton AC, Cowley AWJ. Dissociation of renal blood flow and filtration rate autoregulation by renin depletion. Am J Physiol Renal Physiol 1977; 232:F215-F221. (Pubitemid 8077467)
5. Rosivall L, Youngblood P, Navar L. Renal autoregulatory efficiency during angiotensin-converting enzyme inhibition in dogs on a low sodium diet. Renal Physiol 1986; 9:18-28. (Pubitemid 16153690)
6. Krum H, Schlaich M, Whitbourn R, Sobotka PA, Sadowski J, Bartus K, et al. Catheter-based renal sympathetic denervation for resistant hypertension: a multicentre safety and proof-of-principle cohort study. Lancet 2009; 373:1275-1281.
7. Head GA, Burke SL. Are centrally acting imidazoline agents appropriate therapy for renovascular hypertension? In: Piletz JE, Regunathan S, Ernsberger P, editors. Agmatine and imidazolines: their novel receptors and enzymes. New York: Annals of the New York Academy of Sciences; 2003. pp. 234-243. (Pubitemid 38265113)
8. Johansson M, Herlitz H, Jensen G, Rundqvist B, Friberg P. Increased cardiovascular mortality in hypertensive patients with renal artery stenosis. Relation to sympathetic activation, renal function and treatment regimens. J Hypertens 1999; 17:1743-1750.
9. Tibirica E, Feldman J, Mermet C, Monassier L, Gonon F, Bousquet P. Selectivity of rilmenidine for the nucleus reticularis lateralis, a ventrolateral medullary structure containing imidazoline-preferring receptors. Eur J Pharmacol 1991; 209:213-221.
10. Head GA, Burke SL, Chan CK. Site and receptors involved in the sympathoinhibitory actions of rilmenidine. J Hypertens Suppl 1998; 16:S7-S12. (Pubitemid 28433254)
11. Licata G, Scaglione R, Guillet C, Capuana G, Parrinello G, Indovina A, et al. Double-blind controlled study of rilmenidine versus hydrochlorothiazide in mild hypertension: clinical and renal haemodynamic evaluation. J Hum Hypertens 1993; 7:153-157. (Pubitemid 23138191)
12. Schachter M, Luszick J, Jager B, Verboom C, Sohlke E. Safety and tolerability of moxonidine in the treatment of hypertension. Drug Saf 1998; 19:191-203. (Pubitemid 28432928)
13. Head GA, Burke SL. Sympathetic responses to stress and rilmenidine in 2K1C hypertensive rabbits: evidence of enhanced nonvascular neuroeffector mechanism. Hypertension 2004; 43:636-642. (Pubitemid 38282440)
14. Burke SL, Head GA. Cardiac and renal baroreflex control during stress in conscious renovascular hypertensive rabbits: effect of rilmenidine. J Hypertens 2009; 27:132-141.
15. Burke SL, Evans RG, Head GA. Effects of chronic sympatho-inhibition on reflex control of renal blood flow and plasma renin activity in renovascular hypertension. Br J Pharmacol 2010; 159:438-448.
16. Morgan T. The use of centrally acting antihypertensive drugs in patients with renal disease. Chest 1983; 83:383-386. (Pubitemid 13153332)
17. Parkin ML, Godwin SJ, Head GA. Importance of imidazoline-preferring receptors in the cardiovascular actions of chronically administered moxonidine, rilmenidine and clonidine in conscious rabbits. J Hypertens 2003; 21:167-178. (Pubitemid 36143522)
18. Dorward PK, Riedel W, Burke SL, Gipps J, Korner PI. The renal sympathetic baroreflex in the rabbit. Arterial and cardiac baroreceptor influences, resetting, and effect of anesthesia. Circ Res 1985; 57:618-633. (Pubitemid 16233128)
19. Burke SL, Head GA. Method for in-vivo calibration of renal sympathetic nerve activity in rabbits. J Neurosci Methods 2003; 127:63-74. (Pubitemid 36809235)
20. Oliver JR, Korner PI, Woods RL, Zhu JL. Reflex release of vasopressin and renin in haemorrhage is enhanced by autonomic blockade. Am J Physiol Heart Circ Physiol 1990; 258:H221-H228. (Pubitemid 20063132)
21. Denton KM, Anderson WP, Korner PI. Renal blood flow and glomerular filtration rate in renal wrap hypertension in rabbits. J Hypertens 1983; 1:351-355. (Pubitemid 14163558)
22. Head GA, Burke SL. Renal and cardiac sympathetic baroreflexes in hypertensive rabbits. Clin Exp Pharmacol Physiol 2001; 28:972-975. (Pubitemid 34053503)
23. Ludbrook J. Repeated measurements and multiple comparisons in cardiovascular research. Cardiovasc Res 1994; 28:303-311. (Pubitemid 24131066)
24. DiBona GF. Sympathetic nervous system and the kidney in hypertension. Curr Opin Nephrol Hypertens 2002; 11:197-200.
25. Hackam DG, Duong-Hua ML, Mamdani M, Li P, Tobe SW, Spence JD, et al. Angiotensin inhibition in renovascular disease: a population-based cohort study. Am Heart J 2008; 156:549-555.
26. Chan CKS, Head GA. Relative importance of central imidazoline receptors for the antihypertensive effects of moxonidine and rilmenidine. J Hypertens 1996; 14:855-864. (Pubitemid 26237206)
27. Penner SB, Smyth DD. The role of the peripheral sympathetic nervous system in the natriuresis following central administration of an I-1 imidazoline agonist, moxonidine. Br J Pharmacol 1995; 116:2631-2636.
28. Penner SB, Smyth DD. Renal denervation altered the hemodynamic and renal effects following intracerebroventricular administration of the I-1-imidazoline receptor agonist, rilmenidine, in pentobarbital anaesthetized rats. Neurochem Int 1997; 30:55-62. (Pubitemid 27032544)
29. Ritz E, Amann K, Fliser D. The sympathetic nervous system and the kidney: its importance in renal diseases. Blood Press Suppl 1998; 3:14-19. (Pubitemid 29185400)
30. Smyth DD, Penner SB. Imidazoline receptor mediated natriuresis: central and/or peripheral effect? J Auton Nerv Syst 1998; 72:155-162. (Pubitemid 28522191)
31. Smyth DD, Pirnat D, Forzley B, Penner SB. Apparent absence of direct renal effect of imidazoline receptor agonists. Ann N Y Acad Sci 2003; 1009:288-295. (Pubitemid 38265122)
32. Evans RG. Current status of putative imidazoline (I1) receptors and renal mechanisms in relation to their antihypertensive therapeutic potential. Clin Exp Pharmacol Physiol 1996; 23:845-854. (Pubitemid 26361704)
33. Evans RG, Anderson WP. Renal effects of infusion of rilmenidine and guanabenz in conscious dogs: contribution of peripheral and central nervous system alpha(2)-adrenoceptors. Br J Pharmacol 1995; 116:1557-1570.
34. Evans RG, Shweta A, Malpas SC, Fitzgerald SM, Anderson WP. Renal effects of rilmenidine in volume-loaded anaesthetised dogs. Clin Exp Pharmacol Physiol 1997; 24:64-67. (Pubitemid 27101492)
35. Leary WP. Renal excretory actions of antihypertensive agents. Effects of rilmenidine. Am J Med 1989; 87:63S-66S. (Pubitemid 19248371)
36. Wiecek A, Fliser D, Nowicki M, Ritz E. Effect of moxonidine on urinary electrolyte excretion and renal haemodynamics in man. Eur J Clin Pharmacol 1995; 48:203-208.
37. Bie P, Wamberg S, Kjolby M. Volume natriuresis vs. pressure natriuresis. Acta Physiol Scand 2004; 181:495-503. (Pubitemid 39078847)
38. Bie P, Sandgaard NC. Determinants of the natriuresis after acute, slow sodium loading in conscious dogs. Am J Physiol 2000; 278:R1-R10. (Pubitemid 30182665)
39. Cechetto DF, Kline RL. Effect of rilmenidine on arterial pressure and urinary output in the spontaneously hypertensive rat. Eur J Pharmacol 1997; 325:47-55. (Pubitemid 27190455)